Diacylglycerol kinase alpha is a proliferation marker of intrahepatic cholangiocarcinoma associated with the prognosis
Cancer Medicine · 2024
DOI: 10.1002/cam4.7238 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Shunsuke Shichi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery I, Hokkaido University Graduate School of Medicine, Sapporo, Japan. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Diacylglycerol Kinase, Biomarkers, Tumor, Bile Duct Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Ono Pharmaceutical Co., Ltd., Ministry of Education, Culture, Sports, Science and Technology.
Abstract (Originalsprache)
Background
Intrahepatic cholangiocarcinoma (ICC) has a high recurrence rate and a poor prognosis. Thus, the development of effective treatment and prognostic biomarkers is required. High expression of diacylglycerol kinase alpha (DGKα) is a prognostic factor for the recurrence of hepatocellular carcinoma. However, the relationship between DGKα expression and prognosis in ICC has not been reported.
Methods
Immunohistochemistry (IHC) with anti‐DGKα antibody was performed on surgical specimens of ICC ( n = 69). First, DGKα expression in cancer cells was qualitatively classified into four groups (−, 1+, 2+, 3+) and divided into two groups (DGKα− and DGKα+1 + to 3+). The relationship between clinical features and DGKα expression was analyzed. Second, Ki‐67 expression was evaluated as a cell proliferation marker. The number of Ki‐67‐positive cells was counted, and the relationship with DGKα expression was examined.
Results
DGKα IHC divided the patients into a DGKα+ group (1+: n = 15; 2+: n = 5; 3+: n = 5) and a DGKα− group (−: n = 44). In the DGKα+ group, patients were older and had advanced disease. Both overall survival and recurrence‐free survival (RFS) were significantly worse in the DGKα+ patients. DGKα+ was identified as an independent prognostic factor for RFS by multivariate analysis. Furthermore, the number of Ki‐67‐positive cells increased in association with the staining levels of DGKα.
Conclusion
Pathological DGKα expression in ICC was a cancer proliferation marker associated with recurrence. This suggests that DGKα may be a potential therapeutic target for ICC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterological Surgery I, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
ORCID-Profile: Shunsuke Shichi, Kazuki Wakizaka
Förderung
- Japan Agency for Medical Research and Development
- Ono Pharmaceutical Co., Ltd.
- Ministry of Education, Culture, Sports, Science and Technology
- Ono Pharmaceutical
Zitieren
APA
Shichi, S., Sugiyama, K., Asahi, Y., Shirakawa, C., Nakamoto, H., Kimura, S., Wakizaka, K., Aiyama, T., Nagatsu, A., Orimo, T., Kakisaka, T., & Taketomi, A. (2024). Diacylglycerol kinase alpha is a proliferation marker of intrahepatic cholangiocarcinoma associated with the prognosis. Cancer Medicine. https://doi.org/10.1002/cam4.7238
Vancouver
Shichi S, Sugiyama K, Asahi Y, Shirakawa C, Nakamoto H, Kimura S, et al. Diacylglycerol kinase alpha is a proliferation marker of intrahepatic cholangiocarcinoma associated with the prognosis. Cancer Medicine. 2024. doi:10.1002/cam4.7238
BibTeX
@article{Shichi2024,
author = {Shichi, Shunsuke and Sugiyama, Ko and Asahi, Yoh and Shirakawa, Chisato and Nakamoto, Hiroki and Kimura, Saori and Wakizaka, Kazuki and Aiyama, Takeshi and Nagatsu, Akihisa and Orimo, Tatsuya and Kakisaka, Tatsuhiko and Taketomi, Akinobu},
title = {Diacylglycerol kinase alpha is a proliferation marker of intrahepatic cholangiocarcinoma associated with the prognosis},
journal = {Cancer Medicine},
year = {2024},
doi = {10.1002/cam4.7238}
}
EUVIMED